< BACK TO PRESS RELEASES LISTING
Monday, June 20, 2016
Houlihan Lokey Expands Board with Appointment of Dr. Jacqueline Kosecoff
LOS ANGELES and NEW YORK – June 20, 2016 – Houlihan Lokey (NYSE: HLI), the global investment bank, today announced that it has appointed Jacqueline Kosecoff, Ph.D. to its Board of Directors, (“Board”) as an independent director. The appointment is effective immediately, and she will stand for election to the Board at the 2016 annual meeting of shareholders. Dr. Kosecoff will serve on the Audit Committee and the Nominating and Corporate Governance Committee. With the addition, the Board expands to eleven members, three of whom are independent.
“I am pleased to welcome Jacqueline to our board as an independent director,” said Irwin N. Gold, Executive Chairman and Director of Houlihan Lokey. “Her expertise, including experience serving on several public company boards, will add a valuable perspective as we continue building a global business. We look forward to benefiting from her contributions.”
Dr. Kosecoff works in private equity as a Managing Partner of Moriah Partners. She has been in this role since 2012.
From 2002 to 2012, Dr. Kosecoff was a senior executive with UnitedHealth Group-PacifiCare. She joined UnitedHealth Group as part of its acquisition of PacifiCare Health Systems in 2005. Prior to joining UnitedHealth Group-PacifiCare, Dr. Kosecoff was founder, President and Chief Operating Officer of Protocare, a firm whose lines of business included the clinical development of drugs, devices, biopharmaceutical and nutritional products, and health services consulting. Dr. Kosecoff was also co-founder and Co-CEO of Value Health Sciences (VHS), a wholly owned subsidiary of Value Health, Inc. (NYSE: VHI).
A seasoned member of corporate boards of directors, Dr. Kosecoff sits on the boards of athenahealth, Inc. (NASDAQ: ATHN); Sealed Air Corporation (NYSE: SEE); and, STERIS Corporation (NYSE: STE) and previously served as a director of CareFusion Corporation.
Dr. Kosecoff holds a bachelor of arts degree from the University of California, Los Angeles (UCLA), a master of science in applied mathematics from Brown University, and a Ph.D. degree in research methods from UCLA.
Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, the Middle East, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firm's commitment to client success across its advisory services. Houlihan Lokey is ranked as the No. 1 M&A advisor for all U.S. transactions, the No. 1 global restructuring advisor, and the No. 1 global M&A fairness opinion advisor over the past 20 years, according to Thomson Reuters.
For press inquiries, contact
PR@HL.com or 212.331.8223.